Sika Acquires Industrial Flooring Business Specializing in Polyurethane and Epoxy

Sika AG acquired the commercial and industrial polymer flooring business of The Valspar Corporation. The transaction closed on January 9, 2008. Revenues for this business totaled approximately US$ 17 million for the fiscal year ended October 26, 2007.

Already a market leader in construction chemicals including adhesives and sealants, concrete admixtures, repair and strengthening products, Sika expects that this acquisition will further strengthen its North American position in the polymer flooring market. Approximately 27 employees are expected to join Sika as part of the transaction. The parties have agreed not to disclose the sale price.

The Valspar polymer flooring business, with its strong portfolio of epoxy and polyurethane technology products, is an excellent fit for Sika’s focused growth strategy for North America, where its position in the flooring business was weak for historical reasons. With an established, well-respected range of products, people, applicators and distributors, the Valspar polymer flooring business greatly enhances and complements Sika’s current position in this key market.

The acquisition also creates for Sika the most comprehensive range of epoxy, polyurethane, and other key polymer flooring products and technologies in the industry. Sika is confident that the Valspar flooring business, when combined with Sika’s broad offering of sales and support services, will enable Sika to offer even greater value to its polymer flooring customers. Today with the exception of North America Sika is the worldwide leader in the industrial flooring market.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.